Josh Mandel-Brehm - Apr 1, 2025 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Chief Executive Officer, Director
Signature
/s/ Josh Mandel-Brehm
Stock symbol
CAMP
Transactions as of
Apr 1, 2025
Transactions value $
$0
Form type
4
Date filed
4/3/2025, 04:06 PM
Previous filing
Oct 15, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAMP Stock Option (Right to Buy) Award $0 +160K $0.00 160K Apr 1, 2025 Common Stock 160K $3.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant.